首页> 外国专利> In vitro detection of resistance to oxaliplatin in cancer cells, by measuring mitochondrial apoptosis, and the use of stimulators of mitochondrial apoptosis to overcome resistance

In vitro detection of resistance to oxaliplatin in cancer cells, by measuring mitochondrial apoptosis, and the use of stimulators of mitochondrial apoptosis to overcome resistance

机译:通过测量线粒体凋亡来体外检测癌细胞中对奥沙利铂的耐药性,并利用线粒体凋亡刺激剂克服耐药性

摘要

An in vitro method for detecting resistance of cancer cells (CC) to treatment with oxaliplatin (I) comprises measuring mitochondrial apoptosis of CC that have been, or could be, treated with (I), or before treatment, is new. Independent claims are also included for: (1) a similar method comprising detecting at least one mutation that indicates a defect in mitochondrial apoptosis when cells are treated with (I), particularly a mutation in a region of the Bax gene that contains a series of 8 deoxyguanines; (2) method for selecting agents (II) that inhibit resistance of CC to (I); (3) use of at least one agent (III) that stimulates mitochondrial apoptosis to prepare a composition for use in patients with (or at risk of developing) resistance to (I); (4) product/composition containing (I) and at least one (III); (5) kit for diagnosing resistance of cancer to (I); and (6) the cell HCT116/S, deposited as CNCM I-3051.
机译:一种检测癌细胞(CC)对奥沙利铂(I)的抗药性的体外方法,包括测量已经或可以用(I)治疗的CC或治疗前的CC的线粒体凋亡。还包括以下方面的独立权利要求:(1)一种相似的方法,包括当用(I)处理细胞时检测至少一个指示线粒体凋亡缺陷的突变,特别是Bax基因区域中的突变,该突变包含一系列8个脱氧鸟嘌呤; (2)选择抑制CC对(I)的抗性的试剂(II)的方法。 (3)使用至少一种刺激线粒体细胞凋亡的试剂(III)来制备用于对(I)抗药性(或有发展为抗药性的患者)的组合物; (4)包含(I)和至少一种(III)的产品/组合物; (5)用于诊断癌症对(I)的抗性的试剂盒; (6)储存为CNCM I-3051的单元HCT116 / S。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号